JPRN-UMIN000007539
Completed
未知
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR Study - Remission induction by Raising the dose of Remicade in RA Extension study (RRRR-EX Study)
niversity of Occupational and Environmental Health, Japan0 sites108 target enrollmentApril 1, 2012
ConditionsRheumatoid Arthritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis
- Sponsor
- niversity of Occupational and Environmental Health, Japan
- Enrollment
- 108
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who discontinued IFX treatment prior to 54 week from the first administration of IFX in the RRRR Study 2\) Patients who are inadequate to enter this trial due to the other reasons by physician's judgments
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, through application of musculoskeletal ultrasonography and treatment for periodontal disease, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014886agasaki University Hospital250
Recruiting
Not Applicable
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014881agasaki University Hospital250
Active, not recruiting
Phase 1
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritisEUCTR2016-002908-15-NLSint Maartenskliniek140
Completed
Not Applicable
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritisJPRN-UMIN000016950Osaka Medical College50
Recruiting
Not Applicable
Refractory Rheumatoid ArthritisM05Seropositive rheumatoid arthritisDRKS00005807Abteilung für RheumatologieMedizinische Universität Wien219